Phase I study of T-3262, A new pyridonecarboxylic acid derivative

CHEMOTHERAPY

Volumn 36, Issue , 1988, Pages 158-180

  Nakashima, Mitsuyoshi ^a   Uematsu, Toshiko ^a   Kanamaru, Mitsutaka ^a   Yasuda, Takashi ^b   Watanabe, Yasuo ^b   Tai, Masaru ^b  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOYAMA CHEMICAL CO LTD   (Japan)

Author keywords

T 3262

Indexed keywords

NEW DRUG; TOSUFLOXACIN; TOSUFLOXACIN TOSILATE;

ADULT; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG HALF LIFE; DRUG SAFETY; DRUG SALIVA LEVEL; FOOD DRUG INTERACTION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PHASE 1 CLINICAL TRIAL;

EID: 0024269498     PISSN: 00093165     EISSN: None     Source Type: Journal    
DOI: 10.11250/chemotherapy1953.36.Supplement9-Base_158     Document Type: Article

References (5)

1. Chemotherapy 36 (S-9): 221~232, 1988.
2. JPn J Antibiot 42 (4).
3. Chemotherapy 36 (S-9): 149~157, 1988.
4. Chemotherapy 36 (S-9): 95~109, 1988.
5. Chemotherapy 36 (S-9): 126~136, 1988.